chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swollen lymph node in armpit on the same arm the vaccine was administered.; This is a spontaneous report from a contactable consumer (Pfizer colleague). A 21-year-old non pregnant female patient received bnt162b2 (PFIZER-BIOTECH COVID-19 VACCINE, Batch/Lot Number: FF2593),  intramuscular, administered in right arm on 21Oct2021 as dose 1, single for covid-19 immunization in Pharmacy or Drug Store. The patient medical history was not reported. The patient didn't receive any other vaccines within 4 weeks prior to the COVID-19 vaccine and she was not diagnosed with COVID-19 prior to vaccination. Concomitant medications in two weeks included Steroid Cream. The patient experienced swollen lymph node in armpit on the same arm the vaccine was administered on 27Oct2021. The event was not resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient underwent lab tests and procedures which included Nasal Swab for Covid-19: negative on 26Oct2021(post vaccination). No treatment was taken for the event. The outcome of event was not recovered.  Follow-up attempts are completed. No further information is expected.
After second dose 3/10/21 started having chills, myalgia. On 3/24/21 hospitalized with respiratory failure, kidney failure, heart attack, sepsis and liver malfunction. Had subsequent GI bleed
Left hand went numb after receiving the vaccine. It has been numb now since 11:30 and it's now 1:25. Gave him a Tylenol and put ice pack on it. And is constantly shaking it because of the numbness
Information has been received from a physician concerning a 9 month old male patient who on 05-JUN-1992, was vaccinated with the first dose of RECOMBIVAX HB (dose and route not reported) (lot number 603483/0585V). On 07-AUG-1992, was vaccinate with the second dose of RECOMBIVAX HB (dose, route and lot number not reported). On 07-JAN-1993, was vaccinated with the third dose of RECOMBIVAX HB (dose, route and lot number not reported). The physician stated that the patient received 3 doses of RECOMBIVAX HB and has no titers. At the time of the report the patient had not recovered. Additional information has been requested.
The COVID-19 vaccine administered through the vaccine administrator, between June 25 and July 30 came from the lot number 039K20A.  It was discovered that this particular lot was beyond its frozen expiration date by five (5) up to forty (40) days. A case was opened with Moderna (Case #: MOD21-126790).  Please refer to this case number if you would like to contact Moderna directly.  Moderna confirmed that the vaccine doses administered maintained the activity necessary to protect against the COVID-19 virus.  Moderna also confirmed there is no danger to anyone's health from receiving a vaccine past its frozen expiration date.  No adverse reactions were identified.
Starting on 1/9/22, woke up to swollen itchy sore and red plaque where shot was injected.
Remember left arm at time of injection becoming numb for nearly .5 hour on 9 June 1999. Extreme headache, extreme vomiting, dizziness, blurred vision, abdominal tenderness, chills.  Symptoms persist for 6-8 hours. Taken to ER.  Symptoms began approx. 2000 hrs on 24 June 1999. Taken to ER approx. 0500 hrs on 25 June 1999. Was given 60 Mgm of Toradol. Headache eased and released from hospital Mid morning on 25 June 1999.  Maintained headache for multiple days following ER and controlled the pain with ibuprofen.  7/2/09 Medical records received DOS 10/20/00 to 6/9/09. Assessment: Benign essential hypertension, hypertriglyceridemia, lumbar radiculopathy, sleep disorder. Patient presented with right low back pain extending to popliteal fossa. Facial burning, headaches, periorbital swelling sensation, hypertension. TMJ tenderness. Right neck pain and stiffness, shoulder pain. Excessive daytime sleepiness. Fatigue. Difficulty sleeping. Hands stiff. Witnessed sleep apnea, snores. Intermittent burning sensation and flushing of face.
Rash/hives beginning 1 week after first dose of Moderna COVID-19 vaccine. Most prominent at site of injection, but spread to neck, face, both arms, chest, torso, back, groin, and legs. Prescribed cetirizine, methylPREDNISolone, triamcinolone acetonide. Advised to return to doctor's office after one week for follow-up.
Patient reported experiencing the following starting on 10/31/2020 after lunch: -nausea/vomiting -low grade fever (~99F) -body aches, headache -hip pain exacerbation
Sudden onset of atrial fibrillation, documented in ER visit on 10/22/2023, however likely having some symptoms prior to this, dating back to 10/29/2023.   Previously healthy individual with no risk factors for atrial fibrillation ** I fully acknowledge that this could be a coincidental event, however, the proximity to the vaccination is concerning to me and this is why I am reporting it despite my health care providers feeling that this is not related.  Of note, I am also a physician myself and am very much pro-vaccine**
Patient called office on 12/10/07 to cancel 2nd Gardasil vaccine.  Complained of nausea after 1st injection on 10/18/07, on 10/19/07 noted left side of face red and swollen.  No other symptoms, resolved without any further symptoms.
died; administered in Left leg; This is a spontaneous report from a contactable consumer reported for patient (mother). A 93-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 02Mar2021 administered in Left leg at single dose for COVID-19 immunisation. No other vaccine in four weeks. Medical history included COPD, aortic stenosis, mild dementia, no known allergies. Concomitant medications in two weeks included donepezil, acetylsalicylic acid (ASPIRIN), ascorbic acid/ergocalciferol/nicotinamide/retinol/riboflavin/thiamine hydrochloride (VITAMINS), Blood Pressure Meds. Historical Vaccine included the first dose of BNT162B2 (lot number EL1283) in the right arm on 26Jan2021 09:15 (at the age of 93-years-old) as a single dose for COVID-19 immunization and experienced prolonged tiredness, increased weakness, dragging right foot when walks, little more trouble swallowing pills than before on 27Jan2021.  The patient died three weeks later on 29Mar2021, she received treatment included ambulance. Care providers thought rapid decline after vaccine. The death cause was unknown, no autopsy was performed. No COVID prior vaccination, no COVID tested post vaccination.     Information on the lot/batch number has been requested.; Reported Cause(s) of Death: died
Chest tightness, sciatic pain (never experienced) started at 8am, fever of 103 with immediate spike (15minutes) began at 5pm with body aches, chills and nausea.
pt devel generalized myalgias, fatigue, numbness of fingers to forearms 2wk p/vax; condition has persisted to present;
Injection site became hard and red, hot on the day of vaccination and day after. The red lump has stayed for 7 days so far. The vaccine also triggered a series of cluster headaches, which happens to me. Instead of the vaccine causing one headache I had about 8 over the course of 4 days.
severe arm pain, dizziness, nausea the first day, 2nd day syncope with seizure like activity, 3rd day syncope with seizure like activity, 4th day syncope with seizure like activity. continued syncope several times daily with seizure like activity since shot was administered.  Put on heart monitor, no issues, labs checked, no known cause, scheduled for EEG, still having multiple syncope daily with seizure like activity
Went to bed and woke up with blood dripping from teeth, had blood clots under top lip.  Younger had blood and a little dried blood on face (under lips.  Brushed teethe and wronged mouth, looked like slow if still dripping at all- went back to bed and woke up about 3 hours later with the same bloody younger, gums, younger, etc and more blood clotting.  Have had minor bleeding from gums throughout the day.  I don?t have gum issues and don?t recall the last time they bled.
Pediatric dose (0.2 ml) was drawn up from Adult Pfizer vial. 8 year-old patient received 0.2 ml of the 12+ Pfizer vaccine. the partent sof the patient were notified as soon as it was discovered and told to monitor child for adverse effects. Child developed a 100.5 degree Farenheit fever at 1 am on 12/03/2021. Parent is keeping the child home from school on 12/03/2021 and giving alternating Tylenol and ibuprofen.
Client returned to clinic approximately 5-10 min. after the vaccine was given, with a rash/itching/mild welts on chest and very few on abdomen. 25mg of Benadryl given po. Repeated Benadryl about 15 min. later, as itching was increased and rash on to back. About 10 min. later, symptoms improved and client was released.
UTI; This is a spontaneous report from a non-contactable consumer (patient) via a sponsored program. A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient wanted to know if the second dose of Covid vaccine can be received dose if she had a UTI and take Macrobid that developed after first dose on an unspecified date. Outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
day p/vax devel t101;had blotchy spots hwich have disappeared;c/o h/a, low energy, no appetite;father reports current s/s as of 27MAR97;pt recv hep b dose 2 on 25APR97 w/no reported adverse event;
After the 2nd dose the area of the injection became swollen and increasingly sore over several hours. By the next day there was edema around the injection site. Over a few days the skin over the triceps and deltoid muscle looked bruised and discolored. The acute soreness dissipated over about two weeks and was replaced by chronic joint stiffness and muscle soreness. Some loss of range of motion in the shoulder occurred initially, however this has been mostly regained with exercise. The shoulder joint does not move freely and I can feel irregularity in the joint through its range of motion.  Their is chronic weekness in the deltoid, mostly in the posterior section.
Pounding and rushing of heart has been ongoing in the weeks after I got the shot. Feels like my heart is too big for my chest cavity. A little shortness of breath.
Information has been received on 17-JUL-2017 from a medical assistant regarding a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 17-JUL-2017 the patient was inadvertently administered an expired dose of GARDASIL lot # L040460, expiration 27-MAY-2017 intramuscular for the prevention of HPV. No adverse effects reported. Additional information was received on 17-JUL-2017 from a medical assistant via a company employee. The medical assistant confirmed the administered expired vaccine as GARDASIL not GARDASIL 9. No further information was reported. Additional information was received on 18-JUL-2017 from the physician. The physician called to confirm the expired GARDASIL and requested information from post-expiry memo as to how long the potency is supported. Additional information has been requested.
Atrial fibrillation; Fast heartbeat; A spontaneous report was received from a consumer, an 83 year-old female patient, who received Moderna's Covid-19 vaccine (mRNA 1273), and who experienced atrial fibrillation and fast heartbeat/heart rate increased.  The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included thyroid medications and medications for poor blood flow (not specified).  On 14-FEB-2021, approximately 12 hour prior to the onset of symptoms, the patient received first of two planned dose of mRNA-1273 (Batch Number -011MZ0A) intramuscularly for prophylaxis of Covid-19 infection.  On 14-FEB-2021 the patient went to an emergency room due to fast heartbeat and atrial fibrillation. The treatment for the event included tachycardia converser.  Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events, atrial fibrillation and fast heartbeat, were considered unknown.; Reporter's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.
within 24 hours of the injection I developed sudden hearing loss in my left ear and tinnitus.  The hearing came back within a week but the tinnitus has been permanent.  I had read online that most side effects resolve within 2 weeks, so I didn't call my doctor until I still had the problem a couple weeks later.  Apparently I should have called sooner because he gave me some steroids but said it is better to start them sooner rather than later.  After the steroids did not improve the tinnitus I was referred to ENT.  They checked to see if there was anything noted as an underlying cause and found none.  The staff there reassured me that I was not the only one who has this reaction with a vaccine.  There is no treatment except counseling to manage any emotional reaction to the tinnitus, and distracting oneself from the sound.  This tinnitus has been present for greater than a year.
This spontaneous report was received from a registered nurse regarding an unspecified number of patients of unknown age and gender. In 2016 (after 29-MAR-2016), the patients were vaccinated with improperly stored doses of M-M-R II lot # L001336 with exp. 13-JAN-2017 and lot # L023385 with exp. 25-JUN-2017 (route and doses were not provided). The vaccines were exposed to 14C for 24 hours between 18-MAR-2016 and 29-MAR-2016. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
I had periodic chest pain when lying down after my first shot that I had never previously experienced. About a week after my second shot, i became... acutely aware of the movement of my heart and occasional twinging pain in my chest no matter my body orientation. I wrote it off then, but it has been nearly a month and the pain / discomfort in my chest makes itself known at least once a day . I've adjusted and gotten used to it, but every once in a while a strong twinge will scare me
Mother describes arm as red and swollen. Very concerned about situation. Instructed per telephone conversation to visit PMD and call us back. 8/15/03 visited PCP.
PFIZER VACCINE WAS PLACED IN FREEZER 05062021 AND DUE TO BE MOVED TO REFRIGERATOR 05192021.  VACCINE WAS LEFT IN FREEZER UNTIL 05212021 THEN MOVED TO REFRIGERATOR.  THE IMMUNIZATION PROGRAM WAS NOTIFIED OF ISSUE ON 05252021 AND SENT EMAIL STATING  VACCINE AS SAFE TO USE .   05272021 TIP EMAILED  VACCINE WAS NOT SAFE TO USE AND TO DESTROY THE VACCINE.  THEN TIP EMAILED 05282021 THAT PFIZER PHARMACIST HAD DEEMED VACCINE STABLE AND IT WAS SAFE TO USE SO DOSES GIVEN 05252021 WERE GOOD.
Day 7 after injection: itching at the injection site Day 8 after injection: continued itching, plus swelling and redness at the injection side. Red lesion about 3?x2?
Tested positive for COVID-19 while fully vaccinated. Received doses on 1/28/2021; 2/18/2021
Patient reported swelling, redness and tenderness in the vaccinated arm for the 3-7 days following administration, but was mostly concerned at day 10 that she could still feel a "knot" where the immunization was administerd. She also reported that she has never had a reaction to any immunization like this, but that it had improved over time.
Second COVID vaccine on 1/14/21 - The patient is  received her second dose of Pfizer vaccine at Hospital.   Post dose she experienced intermittent sensation of tingling on left posterior neck area with no paresthesia and difficulty lifting bilateral extremities.  Three days after administration of the vaccine she began noticing weakness in her legs that eventually progressed to her arms bilaterally.   She developed pitting edema and SOB.   Per infectious disease MD, the main suspicion is for GBS Guillain-Barre Syndrome given exam findings. Pt's weakness and resulting inability to ambulate may have pushed pt into CHF exacerbation.   Patient received 3 days of IVIG which was discontinued due to worsening mental status.   Naranjo scale score of 2 indicates possible ADR.
20 minutes after administration, left bottom lip started to tingle and then tip of tongue began to tingle. Also feeling of "unwellness".  These symptoms resolved in 3 1/2 hours.  The next morning, felt as though I was coming down with  illness.  this resolved by afternoon.
Severe pain in entire arm. Could not move it. Pulse rate 121 Temp. 104.6.
30-45 min. post-administration the patient reported itching & swelling of both hands. Patient was given 2 diphenhydramine 25 mg tablets and was monitored an additional 10-15 minutes before being taken home by wife. Follow up call he was doing fine.
Unknown minor surgery; This spontaneous case was reported by a consumer and describes the occurrence of SURGERY (Unknown minor surgery) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SURGERY (Unknown minor surgery). The patient was treated with CEPHALEXIN HCL at an unspecified dose and frequency. At the time of the report, SURGERY (Unknown minor surgery) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided.   Reporter did not allow further contact
7/21/22 awoke with dry scratchy throat, tested negative on binax rapid antigen test- that evening developed a low grade temp and tested positive on roche home covid test
This spontaneous report as received from a 64 year old female patient concerning herself. Pregnancy was reported as no. No drug reaction/allergy was reported. Pertinent medical history included multiple sclerosis (M.S.). On an unknown date in January 2013, the patient was vaccinated with ZOSTAVAX, injection, (lot # and expiry date were unknown) one vaccine. Concomitant therapies included valacyclovir hydrochloride for multiple sclerosis (M.S.) and other medications were taken a the time of vaccination, patient stated that she had taken a ton of medications, but none of them were listed in the article. Patient had been taking valacyclovir for years. She read an article in magazine stating that Antiviral medications may interfere with the replication of the live virus so anyone taking valacyclovir, regularly should discontinue use 24 hours before administration and up to two weeks after. Patient spoke with her Neurologist concerning the fact that she was unaware and thus did not temporarily discontinue use of valacyclovir when she had ZOSTAVAX administered to her in January of 2013. Event onset date was also reported as March 2014. Patient sought medical attention. Treatment given for adverse event was reported as no. No lab diagnostics studies were performed. No (Product Quality Complain) PQC was involved. The outcome of event was unknown. Additional information has been requested.
Pt presents to ED from home after having covid vaccine at 1100 today, now stated having HTN, w/ a hx of HTN.   66-year-old female presents to the emergency department after having a COVID vaccine.  States that he received his 1st dose of the 5 0 vaccine at the campus clinic at 11:00 a.m. Earlier today.  States that within 15 minutes of observation he began to feel sweaty and has some palpitations.  Now expresses he feels fatigued. States that he was observed at the vaccination clinic for approximately 1 hour.  Did have something to eat and drink afterward.  Sent to the emergency department for further evaluation.  Denies chest pain or shortness of breath.  Has not had reaction to vaccinations previously.  Was not previously diagnosed with COVID. Patient went to ED later the same day   presenting to the ED for evaluation of facial swelling and fatigue after receiving her first Covid vaccination at 11AM. Patient was seen in ED shortly after receiving the vaccine due to feeling dizzy, sweaty and fatigued. Patient also reported an elevated BP at that time. Labs and EKG were normal in ED. Patient was given a snack and drink and was feeling better at time of discharge. After arriving home, patient started to feel like their lips and tongue were swelling and had pruritus of both hands and abdomen. Patient denies shortness of breath, chest pain, palpitations, dizziness, wheezing, or N/V/D. Denies a history of allergic reactions to previous immunizations.
(L) upper arm rash day after vaccination, flu-like, weak, swollen arm, red. Had received ZOSTAVAX, PNEUMOVAX.
Severe chest pain; This is a spontaneous report from a non-contactable consumer or other non hcp. A 33-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 30Jul2021 at 13:00 (at the age of 33-years-old) as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced severe chest pain on 31Jul2021 at 14:00. Patient received no other vaccine in four weeks. The event resulted in Emergency room/department or urgent care visit. No treatment was given for the event. Prior to vaccination, the patient was not diagnosed with COVID. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the event was recovering.   No follow-up attempts are possible; information about lot/batch number cannot been obtained.
FLESH TONED MACULAR RASH ON ABDOMEN, PRURITIC NO EXCORIATION NOTED, MACULES FROM 2-8CM IRREGULAR EDGES.
After administering vaccine, site was a little puffy/swollen. Did bleed more than usual, enough to prompt me to ask if patient was on blood thinners, which she said no to. Patient then said she felt dizzy, but no pain or soreness in arm above the usual for a vaccine. Patient complained of voices sounding muffled as if listening to radio and static was coming through when others were talking. Patient asked for water. Water given. Temperature was 97.2 F when checked. No pain or trouble moving, flexing arm, puffiness/swelling went down a little. Called mom to come over and pick her up and drive her back to be on the safe side.
This spontaneous report as received from approximately a consumer (patient's mother) regarding an approximately 15-year-old female patient with no pertinent medical history and drug reactions/allergies. Approximately on an unknown date in July 2010, the patient was vaccinated with a dose of GARDASIL (lot number, expiry date, dose and route were not reported). No concomitant medications were reported. The patient's mother reported that after receiving 2 vaccinations of GARDASIL her daughter experienced adverse reactions. On an unknown date in January 2012, the patient developed stomach pains. The doctors had performed the Computed Axial Tomography (CAT) scan and Magnetic Resonance Imaging (MRI) on an unknown date in 2012 to determine the primary issue (the test results were not reported). On an unknown date in May 2012, the patient developed extreme migraine headaches. On an unknown date in August 2012, the patient frequently vomited and suffered from seizures. The patient was a very active person and now after the administration of GARDASIL she was bed ridden, can no longer exercise and go to school. The patient sought medical attention and was treated for the events systematically (details were not provided). The outcome of all the reported events was unknown. Upon internal review, the event suffered from seizures was considered as other medically important event. Additional information has been requested.